Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01235793 · MORE INFO

Limitations, agreements, and source contact

The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma · Source last updated 2018-11-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Enrollment in the clinical trial did not reach the target number of subjects needed to achieve target power and is insufficient to produce statistically reliable results. Clinical trial terminated due to poor enrollment but the outcomes are measured.
point Of Contact
email
Yuliya.Linhares@cshs.org
organization
Cedars-Sinai Medical Center
phone
310-423-4646
title
Yuliya Linhares, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Enrollment in the clinical trial did not reach the target number of subjects needed to achieve target power and is insufficient to produce statistically reliable results. Clinical trial terminated due to poor enrollment but the outcomes are measured.
point Of Contact
email
Yuliya.Linhares@cshs.org
organization
Cedars-Sinai Medical Center
phone
310-423-4646
title
Yuliya Linhares, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice